| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |